LUMINEX CORP
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | |
|---|---|---|---|---|---|---|
| Revenue | $90.4M | $82.4M | $315.8M | $306.6M | $270.6M | $237.7M |
| Operating income | $1.6M | −$3.6M | $27.8M | $37.2M | $21.0M | $37.4M |
| Net income | $654,000 | $3.0M | $18.5M | $29.4M | $13.8M | $36.9M |
| Total assets | $825.5M | $543.7M | $525.2M | $490.5M | $450.7M | $402.6M |
| Total liabilities | $307.8M | $78.9M | $57.5M | $52.6M | $47.0M | $34.0M |
| Equity | $517.7M | $464.9M | $467.7M | $437.9M | $403.7M | $368.5M |
| EPS (diluted) | $0.01 | $0.07 | $0.41 | $0.67 | $0.32 | $0.86 |
| Shares out. | 45.2M | 44.7M | 44.1M | 40.9M | 43.1M | 42.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2020- Operating margin
- 1.8%
- Net margin
- 0.7%
- Return on equity
- 0.1%
- Return on assets
- 0.1%
- Return on capital (ROCE)
- 0.2%
- Liabilities / assets
- 37.3%
- Debt / equity
- 0.59×
- Book value / share
- $11.46
- Revenue growth (YoY)
- 9.7%
- Net income growth (YoY)
- −77.9%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2020- Altman Z″ (distress)
- 5.46safe
- Accruals / assets
- −6.0%clean
- Beneish M-Score
- -3.27normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 6 good- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsJul 14, 2021
- Other material eventJul 9, 2021
- Shareholder vote · Other material eventJun 21, 2021
- Other material eventJun 11, 2021
- Other material eventMay 26, 2021
- Shareholder voteMay 20, 2021
- Entered a material agreement · Amended charter or bylaws · Regulation FD disclosureApr 12, 2021
- Director / officer changeFeb 24, 2021
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.